Literature DB >> 15457575

Apoptosis pathway of liver cells in chronic hepatitis.

Nai-Ling Chen1, Ling Bai, Lin Li, Pei-Lan Chen, Chang Zhang, Chao-Ying Liu, Tao Deng, Hao Chen, Ke-Ming Jia, Zhen-Qiu Zhou.   

Abstract

AIM: To study the pathway of apoptosis in chronic liver disease and the role of mitochondria in programmed cell death.
METHODS: Liver biopsy specimens from 72 cases of chronic hepatitis and 29 cases of post hepatitis cirrhosis were studied. The pro-apoptotic protein Fas, FasL, Bax and the anti-apoptotic protein Bcl-2, Bcl-x(L), Bcl-2 alpha were studied immunohistochemically by SP method. Specimens from 15 cases of chronic hepatitis and post hepatitis cirrhosis were examined for their ultramicrostructures with special attention to their mitochondrial changes. Specimens from 3 normal adults (demised in traffic accidents) were used as control.
RESULTS: The expression of proapoptotic proteins (Fas, FasL, Bax) in hepatocytes was significantly higher in the chronic hepatitis group than in the cirrhosis group (P<0.001). In the study of ultramicrostructure 364 hepatocytes were examined, from 12 cases of chronic hepatitis (including 10 mild cases, 1 moderate case and 1 severe case). Out of 364 hepatocytes 40 (11.0%) hepatocytes were found with various kinds of destruction in their mitochondria. Rupture of the outer membrane of mitochondria and the leakage of matrix from the intermembrane space were definitely demonstrated. The ultramicrostructural changes of mitochondria in the chronic hepatitis group were statistically higher than that in normal adults control group (chi(2)=4.32, P<0.05).
CONCLUSION: The result of the study was in support of the current view that the apoptotic process in chronic hepatitis patients were largely along the intrinsic pathway (mitochondrial pathway), given that the intrinsic and extrinsic pathways could interlinked (converged) at some point on their progression, also it is impossible at present to exclude the possibility that the two pathways could be chosen by hepatocytes in parallel simultaneously.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15457575      PMCID: PMC4611273          DOI: 10.3748/wjg.v10.i21.3201

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice.

Authors:  G Feldmann; D Haouzi; A Moreau; A M Durand-Schneider; A Bringuier; A Berson; A Mansouri; D Fau; D Pessayre
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 2.  The biochemistry of apoptosis.

Authors:  M O Hengartner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

Review 3.  Pathways of apoptosis in lymphocyte development, homeostasis, and disease.

Authors:  Jeffrey C Rathmell; Craig B Thompson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 4.  The mitochondrial apoptosome: a killer unleashed by the cytochrome seas.

Authors:  C Adrain; S J Martin
Journal:  Trends Biochem Sci       Date:  2001-06       Impact factor: 13.807

Review 5.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435].

Authors:  Valeer J Desmet
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

Review 6.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

7.  Regulation of apoptotic signaling pathways in hepatocytes in vivo.

Authors:  Hartmut Jaeschke; Mary Lynn Bajt
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 8.  Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies.

Authors:  Stephanie Greenstein; Kulsoom Ghias; Nancy L Krett; Steven T Rosen
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

9.  Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).

Authors:  Rajani Ravi; Atul Bedi
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

10.  Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.

Authors:  Hua-Chuan Zheng; Jin-Min Sun; Zheng-Li Wei; Xue-Fei Yang; Yin-Chang Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

View more
  2 in total

1.  Significance of increased expression of decoy receptor 3 in chronic liver disease.

Authors:  S Kim; V Kotoula; P Hytiroglou; D Zardavas; L Zhang
Journal:  Dig Liver Dis       Date:  2009-02-04       Impact factor: 4.088

2.  Hepatoprotective effect of ethanolic extract of Curcuma longa on thioacetamide induced liver cirrhosis in rats.

Authors:  Suzy M Salama; Mahmood Ameen Abdulla; Ahmed S AlRashdi; Salmah Ismail; Salim S Alkiyumi; Shahram Golbabapour
Journal:  BMC Complement Altern Med       Date:  2013-03-05       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.